LIR-containing proteins in Danio rerio>> EXPORT DATA
| S.No. | Uniprot ID | Start | End | LIR Sequence | PSSM Score ▲ ▼ | Similar LIR Motifs | Molecular Function | Biological Process | Cellular Component | 
| 151 | A9JRA8 | 649 | 654 | PSFDIV | 11 | ||||
| 152 | A9JRD6 | 376 | 381 | KSFQTL | 11 | ||||
| 153 | A9JRG7 | 389 | 394 | REYQDL | 13 | structural molecule activity (GO:0005198)  | 
		|||
| 154 | B0BF33 | 252 | 257 | GGFVAL | 11 | ||||
| 155 | B0BLX5 | 384 | 389 | ASFTPV | 9 | ||||
| 156 | B0CM22 | 720 | 725 | ASYEKV | 11 | ||||
| 157 | B0F0C7 | 127 | 132 | KDFLHI | 14 | voltage-gated calcium channel complex (GO:0005891)  | 
		|||
| 158 | B0F0C8 | 93 | 98 | KDFLHI | 14 | voltage-gated calcium channel complex (GO:0005891)  | 
		|||
| 159 | B0JZJ6 | 361 | 366 | PGYEPI | 12 | ||||
| 160 | B0R0H7 | 179 | 184 | KDFTEV | 14 | nucleus (GO:0005634)  | 
		|||
| 161 | B0R0M3 | 195 | 200 | AEWTTV | 18 | cell cycle (GO:0007049)  | 
		nucleus (GO:0005634)  | 
		||
| 162 | B0R0N5 | 41 | 46 | AEFQSL | 11 | ||||
| 163 | B0R196 | 345 | 350 | KVYVKV | 7 | ||||
| 164 | B0S4T8 | 479 | 484 | AEYLKV | 11 | ||||
| 165 | B0S4T8 | 669 | 674 | KGYTTV | 11 | ||||
| 166 | B0S4T8 | 1054 | 1059 | PSYVPL | 12 | ||||
| 167 | B0S4T9 | 479 | 484 | AEYLKV | 11 | ||||
| 168 | B0S4T9 | 669 | 674 | KGYTTV | 11 | ||||
| 169 | B0S4Y7 | 750 | 755 | GDWIKV | 20 | ||||
| 170 | B0S523 | 52 | 57 | DSWEII | 22 | T53I2_HUMAN(33-38) DGWLII(4) | |||
| 171 | B0S540 | 297 | 302 | KSFQSL | 10 | intracellular (GO:0005622)  | 
		|||
| 172 | B0S576 | 11 | 16 | PTFEHL | 11 | nucleus (GO:0005634)  | 
		|||
| 173 | B0S577 | 11 | 16 | PTFEHL | 11 | nucleus (GO:0005634)  | 
		|||
| 174 | B0S5A8 | 55 | 60 | EGYISI | 12 | NBR1_HUMAN(730-735) EDYIII(4) | Golgi apparatus (GO:0005794)  | 
		||
| 175 | B0S5B4 | 447 | 452 | KVFQHL | 6 | lipid binding (GO:0008289)  | 
		intracellular (GO:0005622)  | 
		||
| 176 | B0S5D8 | 529 | 534 | RDYDIV | 17 | ||||
| 177 | B0S5D8 | 1494 | 1499 | AEYEPL | 13 | ||||
| 178 | B0S5D8 | 1549 | 1554 | EEYEPI | 14 | ||||
| 179 | B0S5G7 | 110 | 115 | SGFDKL | 12 | ||||
| 180 | B0S5J3 | 108 | 113 | KSFLPL | 10 | nucleotide binding (GO:0000166)  | 
		RNA processing (GO:0006396)  | 
		||
| 181 | B0S5J7 | 264 | 269 | EVFEEV | 8 | membrane (GO:0016020)  | 
		|||
| 182 | B0S5L8 | 1450 | 1455 | EVYISV | 7 | nucleic acid binding (GO:0003676); nucleotide binding (GO:0000166)  | 
		|||
| 183 | B0S5P8 | 216 | 221 | LGFTVV | 9 | TBCD5_HUMAN(785-790) SGFTIV(4) | |||
| 184 | B0S5Q0 | 471 | 476 | EEYEIL | 15 | ||||
| 185 | B0S5R1 | 29 | 34 | DEYEEL | 17 | FUND1_HUMAN(16-21) DSYEVL(4); TBCD5_HUMAN(57-62) KEWEEL(4)  | 
		
		|||
| 186 | B0S5W0 | 13 | 18 | LTFLPL | 9 | extracellular region (GO:0005576)  | 
		|||
| 187 | B0S5Z9 | 612 | 617 | SSFEVI | 13 | signal transducer activity (GO:0004871)  | 
		|||
| 188 | B0S5Z9 | 654 | 659 | STFLDL | 11 | signal transducer activity (GO:0004871)  | 
		|||
| 189 | B0S602 | 2165 | 2170 | LVYIPL | 6 | extracellular region (GO:0005576)  | 
		|||
| 190 | B0S635 | 115 | 120 | GTYVAL | 12 | ||||
| 191 | B0S681 | 185 | 190 | SVYDLL | 9 | ||||
| 192 | B0S681 | 514 | 519 | SDYLPV | 15 | ||||
| 193 | B0S6A9 | 299 | 304 | EVFTVL | 8 | ||||
| 194 | B0S6B4 | 744 | 749 | RTFVKI | 12 | hydrolase activity (GO:0016787)  | 
		|||
| 195 | B0S6B4 | 865 | 870 | SSFLSL | 11 | hydrolase activity (GO:0016787)  | 
		|||
| 196 | B0S6B4 | 1204 | 1209 | SVYLDL | 8 | hydrolase activity (GO:0016787)  | 
		|||
| 197 | B0S6B9 | 125 | 130 | SDFEEL | 17 | ||||
| 198 | B0S6C0 | 125 | 130 | SDFEEL | 17 | ||||
| 199 | B0S6S9 | 895 | 900 | GSFDTI | 12 | nucleotide binding (GO:0000166)  | 
		|||
| 200 | B0S6T1 | 22 | 27 | SSFTDL | 11 | nucleic acid binding (GO:0003676)  |